Skip Navigation




April 12, 2024

Researchers Discover Cell ‘Crosstalk’ That Triggers Cancer Cachexia

New research from the University of Oklahoma reveals a previously unknown chain of events sparking the development of cancer cachexia, a debilitating muscle-wasting condition that almost always occurs in people diagnosed with pancreatic cancer. The research, led by Min Li, Ph.D., a professor in the OU College of Medicine, is published in the journal Cancer Cell.

April 11, 2024

OU Researcher Receives $3.1M Grant for Clean Hydrogen Technologies

Hanping Ding, Ph.D., an assistant professor in the School of Aerospace and Mechanical Engineering at the University of Oklahoma, has been awarded a $3.1 million grant from the Hydrogen and Fuel Cell Technologies Office in the Department of Energy through the Bipartisan Infrastructure Law to further research in clean hydrogen production. The funding is part of a $750 million effort in President Biden’s Investing in American agenda.

April 10, 2024

Genetic Testing May Provide Improved Medication Therapy Safety and Efficacy for Pediatric Cystic Fibrosis Patients

Second-year University of Oklahoma pediatric resident Dr. Caroline Thompson has a professional and personal connection to cystic fibrosis patient care for children. A childhood friend had the disease and made a lasting impression on Thompson. Now, Thompson has received the Cystic Fibrosis Foundation’s Medical Resident Research Award for a pilot study evaluating pharmacogenomic-directed therapy for pediatric patients at the Oklahoma Cystic Fibrosis Center Tulsa.